Using a device and app for Parkinson's medication
Part of Brain & nervous system clinical trials.
This study tests a new way to take your Parkinson's medication using a special device and an app, with the goal of making it easier to manage your symptoms. You'll use the device for 12 weeks and share your experiences through questionnaires.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 30 years or older and have Parkinson's disease that responds to levodopa.
- You take levodopa at least 4 times a day and your medication has been stable for at least 4 weeks.
- You or your caregiver can learn to use the OraFID device (a device that helps deliver your medication).
- You or your caregiver are willing to fill out questionnaires using a patient app.
- You or your caregiver have a smartphone and can read and write in Swedish.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a smartphone app to track your symptoms and help predict how your medication affects you over time. It aims to improve treatment for people living with Parkinson's disease.
This study tests a new single-dose treatment for Parkinson's disease to see if it can help reduce 'off' time—when medication wears off and symptoms return. It is for people who experience motor fluctuations and are already on a stable medication routine.
This study tests a new form of Parkinson's medication given through a pump to see how well it works in everyday life for people in the early stages of advanced Parkinson's. It may help control symptoms and improve daily function.
This study looks at a new pump treatment (foslevodopa/foscarbidopa) for people with advanced Parkinson's who are having motor fluctuations. It aims to see if it improves quality of life when started earlier in the advanced stage.
This study checks whether measuring levodopa (a Parkinson medicine) in real time can help better understand Parkinson medication effects. You may be asked to wear/perform study monitoring while taking your usual carbidopa/levodopa tablets.
This study is looking at how a new continuous 24-hour injection treatment (foslevodopa/foscarbidopa) affects quality of life in people with advanced Parkinson's disease. It is a real-world study, meaning you just take the medication as your doctor prescribes, and researchers observe the results.
Hear when a new PARKINSON DISEASE (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.